Sanofi (SNY)
NASDAQ: SNY · IEX Real-Time Price · USD
49.96
+0.73 (1.48%)
May 1, 2024, 2:49 PM EDT - Market open
Sanofi Revenue
In the year 2023, Sanofi had annual revenue of $51.60B with 6.87% growth.
Revenue (ttm)
$51.60B
Revenue Growth
+6.87%
P/S Ratio
2.27
Revenue / Employee
$599,438
Employees
86,088
Market Cap
117.18B USD
Revenue Chart
* The company reports in EUR currency but revenue data is shown in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 51.60B | 3.32B | 6.87% |
Dec 31, 2022 | 48.29B | 3.77B | 8.47% |
Dec 31, 2021 | 44.52B | -1.05B | -2.31% |
Dec 31, 2020 | 45.57B | 3.29B | 7.78% |
Dec 31, 2019 | 42.28B | 1.27B | 3.11% |
Dec 31, 2018 | 41.01B | -2.46B | -5.66% |
Dec 31, 2017 | 43.47B | 6.95B | 19.04% |
Dec 31, 2016 | 36.51B | -1.35B | -3.56% |
Dec 31, 2015 | 37.86B | -853.69M | -2.20% |
Dec 31, 2014 | 38.72B | -4.31B | -10.02% |
Dec 31, 2013 | 43.03B | -4.40B | -9.28% |
Dec 31, 2012 | 47.43B | 2.05B | 4.51% |
Dec 31, 2011 | 45.38B | -122.13M | -0.27% |
Dec 31, 2010 | 45.51B | 723.08M | 1.61% |
Dec 31, 2009 | 44.78B | 4.62B | 11.51% |
Dec 31, 2008 | 40.16B | -2.53B | -5.93% |
Dec 31, 2007 | 42.69B | 3.89B | 10.03% |
Dec 31, 2006 | 38.80B | 5.11B | 15.17% |
Dec 31, 2005 | 33.69B | 12.36B | 57.92% |
Dec 31, 2004 | 21.33B | 11.20B | 110.50% |
Dec 31, 2003 | 10.13B | 2.32B | 29.67% |
Dec 31, 2002 | 7.82B | 2.05B | 35.52% |
Dec 31, 2001 | 5.77B | 185.24M | 3.32% |
Dec 31, 2000 | 5.58B | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Cigna | 195.27B |
Elevance Health | 171.75B |
Pfizer | 58.50B |
Medtronic | 32.32B |
Amgen | 28.19B |
Stryker | 20.50B |
Boston Scientific | 14.24B |
Regeneron Pharmaceuticals | 13.12B |
SNY News
- 1 day ago - Press Release: Annual General Meeting of April 30, 2024 - GlobeNewsWire
- 6 days ago - Sanofi Sales, Profit Beat Forecasts - WSJ
- 6 days ago - Sanofi Q1 profit slips on generic competition, forex effects - Reuters
- 6 days ago - Press Release: Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidance - GlobeNewsWire
- 8 days ago - FTC looking to accelerate inquiry into prescription-drug middlemen, chair says - Market Watch
- 8 days ago - Press Release: Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia - GlobeNewsWire
- 12 days ago - Sanofi to overhaul US operations of vaccines, cut jobs - Reuters
- 14 days ago - COTA Announces Strategic Collaboration with Sanofi to Leverage Real-World Data and AI to Accelerate Cancer Trials - Business Wire